13M162: Abstracts: Infection-related Rheumatic Disease (1669–1674)

Presenting Author(s)

• GB

  Genna Braverman, MD (she/her/hers)

  Hospital for Special Surgery
  New York, NY, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• CC

  Camila Caetano, PhD (she/her/hers)

  CLEVELAND CLINIC FOUNDATION
  cleveland, OH, United States

  Disclosure information not submitted.
• JC

  Jeffrey Curtis, MD, MS, MPH

  University of Alabama at Birmingham
  Hoover, AL, United States

  Disclosure(s): AbbVie: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); CorEvitas: Consultant (Ongoing), Grant/Research Support (Ongoing); Eli Lilly and Company: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Myriad: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Sanofi: Consultant (Ongoing), Grant/Research Support (Ongoing); UCB: Consultant (Ongoing), Grant/Research Support (Ongoing)
• Bd

  Benjamin de Valence de Minardiere, MMed

  Université Paris-Est Créteil
  Paris, France

  Disclosure information not submitted.
• RJ

  Rachel Jenkins, MD

  Mayo Clinic
  Rochester, MN, United States

  Disclosure information not submitted.
• AM

  Arthur Mageau, MD, MSc

  Université Paris Cité
  Paris, France

  Disclosure information not submitted.

Abstract oral session.

Non-CME

Presentations:

• 4:00 PM – 4:10 PM PT

  High Incidence of Immune-mediated Inflammatory Diseases in Sepsis Survivors: A Nationwide Exposed-non-exposed Epidemiological Study
  

  Presenting Author: Arthur Mageau, MD, MSc – Université Paris Cité
• 4:10 PM – 4:15 PM PT

  Q&A
  
• 4:15 PM – 4:25 PM PT

  Exacerbation of Immune-mediated Inflammatory Diseases in COVID19 Sequelae
  

  Presenting Author: Camila Caetano, PhD (she/her/hers) – CLEVELAND CLINIC FOUNDATION
• 4:25 PM – 4:30 PM PT

  Q&A
  
• 4:30 PM – 4:40 PM PT

  Use of Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay in Outpatient Rheumatology Practice
  

  Presenting Author: Rachel Jenkins, MD – Mayo Clinic
• 4:40 PM – 4:45 PM PT

  Q&A
  
• 4:45 PM – 4:55 PM PT

  Association of COVID-19 Vaccinations with Flares of Systemic Rheumatic Disease: A Case-Crossover Study
  

  Presenting Author: Genna Braverman, MD (she/her/hers) – Hospital for Special Surgery
• 4:55 PM – 5:00 PM PT

  Q&A
  
• 5:00 PM – 5:10 PM PT

  Immunomodulatory Treatment and Autoimmune Patient Responses to COVID-19 Booster Shots: Results from the Covid-19 VaccinE Response in Rheumatology Patients (COVER) Study
  

  Presenting Author: Jeffrey Curtis, MD, MS, MPH – University of Alabama at Birmingham
• 5:10 PM – 5:15 PM PT

  Q&A
  
• 5:15 PM – 5:25 PM PT

  Severe Infections in Patients with VEXAS Syndrome: A Study from the French VEXAS Group
  

  Presenting Author: Benjamin de Valence de Minardiere, MMed – Université Paris-Est Créteil
• 5:25 PM – 5:30 PM PT

  Q&A